The 2024 forecasted data for global liver malignant neoplasms mortality indicates varied trends across countries. The United States sees the highest mortality with an upward trend of 2.52%, whereas Japan reports a decline of 2.25%. Emerging economies like Brazil reflect growth, and Mexico exhibits a modest increase, suggesting potential healthcare challenges. European countries generally maintain stability with slight variations while Scandinavian nations and smaller European countries show minimal impact, hinting effective healthcare systems. Iceland shows the lowest mortality, emphasizing exceptional healthcare interventions.
Future trends may include technological advancements in early detection, targeted therapies, and public health policies focusing on preventive measures. Monitoring lifestyle factors and healthcare innovations across countries could significantly influence mortality rates globally.
Top countries in Liver Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Female Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 10,300 | 2023 | +2.34% | +2.52% | View data |
| 2 | 2 Japan | 7,940 | 2023 | -2.47% | -2.25% | View data |
| 3 | 3 Brazil | 4,990 | 2023 | +2.17% | +2.7% | View data |
| 4 | 4 Mexico | 3,590 | 2023 | +1.88% | +1.99% | View data |
| 5 | 5 Germany | 2,930 | 2023 | +0.96% | +1.18% | View data |
| 6 | 6 South Korea | 2,750 | 2023 | -0.073% | -0.52% | View data |
| 7 | 7 Canada | 1,260 | 2023 | +2.27% | +2.51% | View data |
| 8 | 8 Romania | 1,140 | 2023 | +0.98% | -0.71% | View data |
| 9 | 9 Colombia | 1,070 | 2023 | +1.79% | +2.53% | View data |
| 10 | 10 Peru | 974 | 2023 | +1.88% | +5.42% | View data |
